Pharmaceutical Business Review
Return to: PBR Home | Suppliers

Using Differential Scanning Calorimetry to Accelerate Liquid Formulation Development for Protein Biopharmaceuticals

Published 29 September 2014 | By Malvern Panalytical

Monoclonal antibody development projects exist for a wide variety clinical indications. Recombinant proteins of commercial interest, including monoclonal antibodies, need additional properties beyond their biological activity to enable their development into successful biopharmaceuticals.

Available Downloads

Using Differential Scanning Calorimetry to Accelerate Liquid Formulation Development for Protein Biopharmaceuticals